These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 29365413)

  • 1. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
    Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
    [No Abstract]   [Full Text] [Related]  

  • 2. NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.
    Wang Y; Cheng J; Xie D; Ding X; Hou H; Chen X; Er P; Zhang F; Zhao L; Yuan Z; Pang Q; Wang P; Qian D
    Cancer Commun (Lond); 2018 Jun; 38(1):33. PubMed ID: 29871674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.
    Yang L; Zhu JY; Zhang JG; Bao BJ; Guan CQ; Yang XJ; Liu YH; Huang YJ; Ni RZ; Ji LL
    Tumour Biol; 2016 Mar; 37(3):4115-26. PubMed ID: 26490982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
    Yang H; Wei YN; Zhou J; Hao TT; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers.
    Xie X; Zhang SS; Wen J; Yang H; Luo KJ; Yang F; Hu Y; Fu JH
    Dis Esophagus; 2014; 27(2):188-95. PubMed ID: 23621299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma.
    Zhang SS; Xie X; Wen J; Luo KJ; Liu QW; Yang H; Hu Y; Fu JH
    Diagn Pathol; 2016 Jan; 11():14. PubMed ID: 26818094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
    Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
    Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma.
    Xie JJ; Xie YM; Chen B; Pan F; Guo JC; Zhao Q; Shen JH; Wu ZY; Wu JY; Xu LY; Li EM
    Oncotarget; 2014 Sep; 5(18):8569-82. PubMed ID: 25149542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
    Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
    Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
    He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
    Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
    Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway.
    Wang T; Zhang P; Chen L; Qi H; Chen H; Zhu Y; Zhang L; Zhong M; Shi X; Li Q
    J Pharmacol Exp Ther; 2022 Jan; 380(1):15-25. PubMed ID: 34740946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.